Alternate-day fasting increases the risk of decreased immune cells and anemia in DSS-induced colitis mice
Frontiers in Nutrition · 17.08.2026 · 13
DOI: 10.3389/fnut.2026.1835068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 17.08.2026. Verfasst von Weijie Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Innate Immunity and Chronic Inflammatory Diseases, Jiangxi Provincial Department of Education, Key Laboratory of Prevention and Tre…. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intermittent fasting (IF) is a widely adopted dietary strategy with well-documented benefits in the management of metabolic diseases. However, its effects in pathological settings characterized by severe tissue injury, such as inflammatory bowel disease (IBD), remain controversial. In this study, we investigated the impact of alternate-day fasting (ADF) on disease activity and immune responses in a mouse model of dextran sulfate sodium (DSS)-induced colitis. Mice were subjected to a 35-day ADF protocol, and acute colitis was induced using 3% DSS initiated 7 days prior to the conclusion of the fasting regimen. Multiple indicators were assessed, including body weight, survival rate, colonic tissue damage and barrier integrity, immune cell profile alterations in the bone marrow and spleen, as well as changes in peripheral blood cell counts. Our results showed that ADF significantly exacerbated colonic inflammation, leading to more severe body weight loss and reduced survival. Histopathological examination revealed that ADF impaired the structural integrity of the colonic mucus layer. Flow cytometric analysis further demonstrated that ADF markedly reduced specific innate immune cell populations in the bone marrow and reduced lymphocyte counts in the spleen. Furthermore, ADF-treated mice exhibited signs of anemia. Taken together, these findings indicate that, in acute DSS-induced colitis, strict ADF intervention does not alleviate intestinal injury but instead exacerbates disease progression by suppressing tissue repair, weakening systemic immune function, and promoting anemia. Therefore, the use of intermittent fasting should be carefully evaluated based on the specific pathological context, and caution is strongly recommended for patients with active inflammatory bowel disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Innate Immunity and Chronic Inflammatory Diseases, Jiangxi Provincial Department of Education, Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Edu…
- Ganzhou People's Hospital (Southern Medical University Ganzhou Hospital / The Affiliated Ganzhou Hospital of Nanchang University), Ganzhou, Jiangxi, China.
- First Affiliated Hospital, Gannan Medical University, Ganzhou, Jiangxi, China.
Zitieren
APA
Shen, W., Lv, H., Wu, Z., Luo, S., Liao, Z., Xu, Z., & Xu, L. (2026). Alternate-day fasting increases the risk of decreased immune cells and anemia in DSS-induced colitis mice. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1835068
Vancouver
Shen W, Lv H, Wu Z, Luo S, Liao Z, Xu Z, et al. Alternate-day fasting increases the risk of decreased immune cells and anemia in DSS-induced colitis mice. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1835068
BibTeX
@article{Shen2026,
author = {Shen, Weijie and Lv, Huiru and Wu, Zhen and Luo, Sicheng and Liao, Zixuan and Xu, Zekai and Xu, Li},
title = {Alternate-day fasting increases the risk of decreased immune cells and anemia in DSS-induced colitis mice},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.1835068}
}
EUVIMED